Tracking Cells Podcast

In this month’s Tracking Cells podcast, we talk with TrakCel’s Alice Clayton, Head of Project Management, and Sean Evans, VP of Technical Delivery, about the intricacies, advantages and considerations of customizing cell therapy orchestration solutions. During this episode, we’ll explore the dynamic landscape of cell therapy orchestration, the process and planning involved in

Explore the challenges of effective patient scheduling within CGT with Andy Case, Head of Supply Chain at Genentech Roche, and Dr Akshay Peer, Senior Vice President of Product and TrakCel co-founder. Delve into the intricacies of managing frequently changing patient schedules, exploring the traditional methods and stakeholders involved. Learn how digitalization, particularly throug

In this insightful episode, we discuss how digital collaboration and a strong eco-system play a vital role in error prevention, efficiency enhancement, and scaling up within the Cell and Gene Therapy industry. We’re joined by experts Dr. Judith Koliwer, Principal Consultant of Cell and Gene Therapy at Körber and Chris Came, Vice President of Global Alliances and Client Services

In this compelling episode, host Helen Hopkins engages in a deep conversation with Edward Armstrong, Vice President of Quality at Mustang Bio, and Matthew Lakelin, VP of Scientific Affairs at TrakCel. Both experts bring a wealth of knowledge and experience to the table, as they explore the intricacies, challenges, and benefits of Cell and Gene Therapy (CGT).Edward’s extensive bac

In Episode Three of the Tracking Cells podcast, we go backstage for an inside peak at TrakCel. We chat with our Senior Technical Delivery Analyst, Thomas Booth, and one of our Project Managers, Adam Harvey. In this episode, we explore in-depth the significance of Chain of Identity (COI) and Chain of Custody (COC) within the cell and gene therapy industry. We also discuss the impact

In Episode two of the Tracking Cells Podcast, we chat to Dale Hanna, Director of Cell and Gene Therapy Solutions at AmerisourceBergen, and Imran Ahmed, Head of Product at TrakCel. Together, they share their thoughts on essential aspects of product development and its impact on CGT therapies. They emphasize the importance of understanding patient needs and creating a seamless user e

In this episode, we have the pleasure of chatting with Lia Sylvestri, the Director of Customer Care and Experience at TrakCel, and Dr Matthew Lakelin, one of TrakCel’s Co-Founders. Together, they shed light on both the challenges and potential of the rapidly evolving cell and gene therapy industry, exploring the significance of standardization, technology integration, early adopt